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Drosophila Myc 
Abstract
Myc genes play a major role in human cancer, and they are important regulators of growth and
proliferation during normal development. Despite intense study over the last three decades, many
aspects of Myc function remain poorly understood. The identification of a single Myc homolog in the
model organism Drosophila melanogaster more than 10 years ago has opened new possibilities for
addressing these issues. This review summarizes what the last decade has taught us about Myc biology
in the fruit fly.
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8057 Zürich, Switzerland; gallant@zool.uzh.ch, +41 44 635 4812 
I. Abstract 
Myc genes play a major role in human cancer, and they are important regulators 
of growth and proliferation during normal development. Despite intense study over 
the last three decades, many aspects of Myc function remain poorly understood. The 
identification of a single Myc homolog in the model organism Drosophila 
melanogaster more than 10 years ago has opened new possibilities for addressing 
these issues. This review summarizes what the last decade has taught us about Myc 
biology in the fruit fly. 
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II. Abbreviations 
BHLHZ basic region-helix-loop-helix-leucine zipper 
CNS central nervous system 
dm diminutive (= Drosophila melanogaster Myc gene) 
Dpp Decapentaplegic (a Drosophila melanogaster TGFβ homolog) 
FRT FLP recombinase target 
GMC ganglion mother cell 
GSC germline stem cell 
H3K4me3 histone H3, trimethylated on lysine 4 
Hh Hedgehog 
Inr Insulin receptor 
MB1/2/3 Myc box 1/2/3 
SID Sin3-interaction domain 
TOR target of rapamycin 
UAS upstream activating sequence 
Wg Wingless (a Drosophila melanogaster Wnt homolog) 
ZNC zone of non-proliferating cells 
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III. Introduction: the Myc/Max/Mxd network in vertebrates 
Myc is amongst the most intensely studied genes in biomedicine - more than 
19ʼ000 articles dealing with Myc can be found in PubMed (Meyer and Penn, 2008). 
Several recent publications have extensively reviewed different aspects of Myc 
function (Dang et al., 2006; Cowling and Cole, 2006; Pirity et al., 2006; Vita and 
Henriksson, 2006; Cole and Cowling, 2008; Eilers and Eisenman, 2008; Meyer and 
Penn, 2008). Therefore, I will only briefly summarize some key features of vertebrate 
Myc proteins. The main part of this review is dedicated to the characterization of Myc 
in the fruit fly Drosophila melanogaster: what this protein does in insects, how it does 
it and how its activity is controlled.  
The “Myc saga” began more than 30 years ago with the identification of the first 
Myc genes as the transforming principles of different avian retroviruses. Subsequent 
research identified the cellular homologs c-, N- and L-Myc in vertebrates. The 
corresponding proteins were found to be frequently overexpressed in human and 
animal tumors and to causally contribute to the development of cancer, as 
demonstrated in numerous animal models. The transforming power of Myc could be 
traced back to Mycʼs ability for influencing a variety of cellular processes, most 
notably growth, cell cycle progression, apoptosis, cell migration, cell adhesion, and 
stem cell behavior. Most of these processes are also controlled by Myc proteins in 
physiological situations and during normal development. Mycʼs versatility is explained 
by its molecular activity as a transcription factor that controls hundreds if not 
thousands of target genes, including genes transcribed by RNA polymerases I, II and 
III. However, each of these targets is only moderately affected by Myc, typically by 2- 
to 3-fold.  
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Myc proteins consist of an N-terminal transcription regulatory domain containing 
the highly conserved “Myc boxes” 1 and 2 (MB1 and MB2), an ill-defined central 
region with another conserved sequence called Myc box 3 (MB3), and a C-terminal 
basic region-helix-loop-helix-leucine zipper domain (BHLHZ), that mediates 
heterodimerization with another BHLHZ-domain protein, Max (“Myc-associated 
protein X”), as well as binding to DNA. Myc:Max heterodimers recognize so-called E-
boxes (CACGTG, and variants thereof), and activate the expression of nearby genes. 
In addition to binding to all members of the Myc family, Max also homodimerizes, and 
it interacts with the Mxd proteins (Mxd1 – 4, formerly known as Mad1, Mxi2, Mad3, 
Mad4, respectively), with Mnt and with Mga. All these Max-partners contain BHLHZ 
domains and their heterodimers with Max control similar genes as Myc:Max dimers, 
but in contrast to Myc:Max heterodimers, they repress the corresponding targets. 
Accordingly, these Max partners function as antagonists of Myc. Besides activating 
many target genes, Myc:Max dimers also repress a distinct set of targets; Myc:Max 
does not recognize these Myc-repressed genes by directly binding to DNA at E-
boxes, but indirectly via the interaction with other DNA-bound transcription factors. 
Finally, Myc has recently also been shown to control DNA replication independently 
of transcription.  
As diverse as the transcriptional targets of Myc are the co-factors recruited by 
Myc to control the expression of these targets. They include the histone 
acetyltransferases GCN5, Tip60 and CBP, the INI1 chromatin remodeling complex, 
the P-TEFb protein kinase that phosphorylates the C-terminal domain of RNA 
polymerase II, and several proteins that have no known enzymatic functions or that 
participate in different multiprotein complexes. For most target genes, it is currently 
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unclear to which extent individual co-factors contribute to their Myc-dependent 
regulation. 
 6 
IV. The Myc/Max/Mnt network in flies 
The search for a Myc/Max/Mxd network in invertebrates was initially motivated by 
the need for a simple model system – a system that contains less gene redundancy 
than vertebrates, that is genetically tractable and that is more easily accessible at all 
stages of development. Widely used models such as yeasts and worms turned out to 
lack Myc genes (although C.elegans contains two Max genes and one gene coding 
for a Mxd-like protein; Yuan et al., 1998), but Drosophila melanogaster fit the bill: fruit 
flies carry one gene each coding for Myc, Max and for a Mad-family member protein. 
Drosophila Myc has even been known to biologists long before the vertebrate Myc 
genes. In 1935, a mutation was described that results in a small adult body size, 
disproportionally small bristles and female sterility (Bridges, 1935). Based on these 
phenotypes, the affected gene was dubbed “diminutive”, abbreviated as “dm”. Many 
years later, molecular cloning revealed the identity of diminutive with the Drosophila 
Myc gene (Gallant et al., 1996; Schreiber-Agus et al., 1997). According to Drosophila 
conventions this gene should therefore be called diminutive/dm; to minimize 
confusion I will refer to the gene and protein as “Myc” in the following text and to the 
mutant alleles as “dmX” (where X is the allele identifier). 
A. Basic properties of the Myc/Max/Mnt proteins in flies 
Drosophila Myc was identified in yeast 2-hybrid screens with human Max as the 
bait (Gallant et al., 1996; Schreiber-Agus et al., 1997). Subsequent 2-hybrid screens 
used first Drosophila Myc as the bait to clone Drosophila Max (Gallant et al., 1996), 
and then Drosophila Max as the bait to fish out Drosophila Mnt (Loo et al., 2005); Mnt 
was also identified independently based on the published Drosophila genome 
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sequence (Peyrefitte et al., 2001). All three proteins show clear sequence similarity to 
their vertebrate counterparts. Thus, Myc is 26 % identical in its overall amino acid 
sequence to human c-, N- and L-Myc, and it contains the conserved sequence motifs 
MB2 (whose role in transactivation and –repression was demonstrated for vertebrate 
Myc) and MB3 (of unknown function), as well as a BHLHZ domain at its C-terminus 
(Figure 1). Furthermore, vertebrate and insect Myc genes have an identical genomic 
organization: in all cases the major open reading frame starts at the beginning of the 
second exon and ends in the third exon, and the second intron interrupts the open 
reading frame at the same codon within the conserved MB3 (reviewed by Gallant, 
2006). 
Drosophila Mnt also shares the functionally identified domains with the vertebrate 
Mnt and Mxd proteins (although the sequence similarity is higher to vertebrate Mnt): 
an N-terminally located SID (“Sin3-Interaction Domain” that mediates binding to the 
transcriptional co-repressor Sin3) and a centrally positioned BHLHZ (Figure 1). 
Interestingly, two Mnt splice variants have been identified that lack either the SID or 
the leucine zipper, suggesting the existence of protein variants that either do not 
repress transcription (MntΔSID) or do not bind to Max and DNA (MntΔZ), and thereby 
might act as antagonists of the full-length variant of Mnt (Loo et al., 2005). Finally, 
Max is the most highly conserved component of the whole network, with 52% overall 
amino acid sequence identity to human Max protein, and an identical genomic 
organization (reviewed by Gallant, 2006). 
The Drosophila Myc, Max & Mnt proteins also share biochemical similarities with 
their vertebrate homologs: in both vertebrates and Drosophila, Myc and Mnt only 
interact with Max, whereas Max is also able to homodimerize (in addition, Myc also 
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has certain functions that are independent of its dimerization with Max, see below). 
Furthermore, in band shift assays all possible types of dimers (Myc:Max, Mnt:Max, 
Max:Max) bind to the same E-box sequence that is also recognized by the 
corresponding vertebrate complexes (and Myc has also been shown to bind an E-
box in a target gene promoter in tissue culture cells; Hulf et al., 2005). Myc:Max 
dimers activate, and Mnt:Max dimers repress, transcription from artificial reporters 
(Gallant et al., 1996; Hulf et al., 2005; Loo et al., 2005). Finally, Drosophila and 
vertebrate Myc proteins can even functionally substitute for each other: Drosophila 
Myc can collaborate with activated Ras to transform rat embryo fibroblasts 
(Schreiber-Agus et al., 1997), and it overcomes the proliferation block in mouse 
embryonic fibroblasts that lack the endogenous c-Myc gene (Trumpp et al., 2001). 
Conversely, human c-MycS (a translation variant of c-Myc with a truncated N-
terminus) rescues the development of flies carrying the lethal Myc allele dmPG45 
(Benassayag et al., 2005).  
These observations show that the Myc/Max/Mnt network has been conserved 
during evolution, and they suggest that whatever we learn about Myc function in flies 
is relevant for our understanding of vertebrate Myc biology. What then is the function 
of Drosophila Myc? 
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B. Biological functions 
As is the case for its vertebrate homologs, overexpression or down-regulation of 
Drosophila Myc affects several cellular processes (Figure 2). Some of these 
processes may be dependent on each other, but the molecular nature of such 
putative connections is as yet unknown, and therefore the individual activities of Myc 
will be treated separately below. However, if there is any unifying theme behind 
Mycʼs different biological activities, it is the control of size. Most of the individual 
activities listed below somehow conspire to control the size of cells, of organs and of 
the whole animal. 
1. Drosophila as an experimental system 
Before delving into the biological properties of Myc and consorts, I need to briefly 
introduce the model system and some of the principal experimental techniques that 
made these analyses possible in the first place. For a more detailed description of 
the biology and experimental analysis of Drosophila melanogaster the reader is 
referred to several excellent treatises (e.g. Greenspan, 2004; Ashburner et al., 2005; 
Dahmann, 2008). 
The fruit fly develops in about 10 days from the egg to the adult (under optimal 
growth conditions at 25°). Along the way, the fly spends 1 day in embryogenesis, 4 
days in larval stages (3 different larval stages, or “instars”), and the last 5 days 
immobilized in a pupal case where it metamorphoses into an adult. Of particular 
interest for scientists studying growth and proliferation is the larval phase, since this 
period is characterized by a massive, 200-fold increase in weight, but as yet little 
cellular differentiation. Most of the larval mass is found in different polyploid tissues, 
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e.g. fat body, salivary gland, and muscles. These tissues attain their final cell number 
already during embryogenesis and afterwards only endoreplicate their genomes 
without undergoing cell division, reaching ploidies of up to 2000 N and accordingly 
large nuclear volumes. During metamorphosis, most of these polyploid tissues are 
histolysed and their contents used by diploid imaginal tissues (abdominal histoblasts 
and imaginal discs that give rise to adult appendages and body wall structures) for 
their own growth. These imaginal discs consist of an epithelial monolayer of columnar 
cells that proliferate near-exponentially during larval phases and are subject to similar 
regulatory mechanisms as typical vertebrate cells.  
A large number of experimental techniques have been developed to manipulate 
these different cell types. For example, by expressing the yeast recombinase FLP 
(from a heat-shock inducible or a tissue-specifically expressed transgene) mitotic 
recombination can be induced between two homologous chromosomes that each 
carry an FRT site (“FLP-recombinase target”), resulting in two daughter cells that are 
homozygous for either the corresponding paternal or maternal chromosome, 
including any mutation that is located on these chromosomes (or more precisely: the 
part of the chromosome that is distal to the FRT site). By following the descendants 
of such homozygous mutant cells (i.e. clones), the properties of mutations can be 
determined in vivo, even if such mutations are lethal at the organismic level and do 
not allow the animals to develop to a stage where they can be analyzed (reviewed in 
Xu and Harrison, 1994). A large number of reagents also exist that allow controlled 
overexpression of transgenes. Many of these rely on the temporally or spatially 
controlled expression of the yeast transactivator GAL4 (by transgenes where specific 
artificial or endogenous enhancers control the expression of GAL4) together with 
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transgenes containing a cDNA under the control of GAL4-responsive UAS elements 
(“upstream activating sequences”). Many hundreds different GAL4 lines and even 
more different UAS lines currently exist. Hence, by crossing such flies together, an 
enormous variety of transgene expression patterns can be achieved (reviewed in 
Brand et al., 1994). The GAL4/UAS- and the FLP/FRT-systems can also be 
combined such that heat-shock induced FLP expression triggers FRT-mediated 
recombination within a GAL4-expressing transgene, leading to the constitutive 
expression of GAL4 (Pignoni and Zipursky, 1997). By keeping the heat-shock 
conditions mild (i.e. incubating the larvae for only a few minutes at the inducing 
temperature) FLP is induced in only a few random cells per animal, and hence GAL4 
can drive the expression of UAS-transgenes in only these few cells. Such cells then 
go on to form clones, and the behavior of these clones (most typically size, shape, 
cell number) can be assayed at freely chosen times after their induction. Such timed 
induction of GAL4 can also be used for polyploid tissues, although the “clones” in 
these tissues only consist of one polyploid cell each (if the heat-shock is given after 
the end of embryogenesis). 
This is only a small selection from the vast and ever-growing “Drosophila toolkit”, 
but I hope that it facilitates the understanding of the following text. 
2. Cellular growth 
The observation of the small adult flies carrying the hypomorphic Myc allele dm1 
immediately revealed Mycʼs involvement in size control (see above, Bridges, 1935). 
In more detailed studies it was later shown that reduction of Myc levels decreases the 
size of larval diploid cells (Johnston et al., 1999) and of Schneider S2 cells grown in 
culture, while at the same time slowing down passage through G1 phase (Hulf et al., 
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2005). As a consequence, cells depleted of Myc accumulate to lower numbers than 
untreated cells (Boutros et al., 2004). Conversely, overexpression of Myc in clones of 
diploid wing imaginal disc cells increases the size of the clones and of the cells 
constituting these clones, without affecting cell number (i.e. division rates). Myc 
overexpression is able to accelerate passage through G1 phase, but these cells 
compensate by extending their G2 phase. When the cell cycle regulator Cdc25/String 
(which is limiting for entry into M-phase) is co-expressed with Myc, both gap phases 
are shortened and cell division times are significantly reduced. Such Myc + 
Cdc25/String co-expressing clones are equally large as clones expressing Myc 
alone, but the former consist of an increased number of normally sized cells, whereas 
the latter contain the same number of cells as control clones, albeit these cells are 
much bigger in size (Johnston et al., 1999). These properties of Myc contrast with 
those of a typical cell cycle regulator such as Cyclin E: down-regulation of Cyclin E 
also impairs progression into S-phase and leads to accumulation of G1-phase cells, 
but at the same time allows growth to continue unabated, thus resulting in bigger 
than normal cells (Hulf et al., 2005). This demonstration that Myc controls cellular 
growth in flies was echoed by similar findings in vertebrates, revealing another 
evolutionary conservation of Myc function (Iritani and Eisenman, 1999; Schuhmacher 
et al., 1999). 
Thus, in addition to its (in vertebrates) long-accepted role in influencing passage 
from G1- to S-phase, Myc also controls the increase in cellular mass. This effect is 
likely to be explained by the nature of Mycʼs transcriptional targets. Like its vertebrate 
homologs, Drosophila Myc controls the expression of a large number of genes, 
possibly many hundreds of them (Orian et al., 2003; Hulf et al., 2005). These genes 
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fall into different functional categories, but many of them play a role in ribosome 
biogenesis, such as the RNA helicase Pitchoune whose vertebrate homolog 
MrDb/DDX18 is also a Myc target (Zaffran et al., 1998; Grandori et al., 1996) and 
Modulo, a putative homolog of the vertebrate Myc target Nucleolin (Perrin et al., 
2003; Greasley et al., 2000). Myc also contributes to ribosome biogenesis by 
stimulating RNA polymerases I and III (Grewal et al., 2005; Steiger et al., 2008), as 
do its vertebrate counterparts (Gomez-Roman et al., 2003; Arabi et al., 2005; 
Grandori et al., 2005). In contrast to vertebrates, however, the activation of RNA 
polymerase I by Myc occurs indirectly, presumably via the RNA polymerase II-
dependent activation of RNA polymerase I cofactors such as TIF-1A (Grewal et al., 
2005). Thus, activation of Myc presumably leads to a general increase in cellular 
translational capacity, resulting in increased growth. 
Interestingly, the different proteins that have been shown to promote an increase 
in cell size (i.e. “growth”) do so in qualitatively different ways. Thus, the insulin 
receptor (Inr) pathway differs from Myc in that it has a prominent effect on the 
cytoplasmic volume of polyploid cells and on the level of the second messenger 
phosphatidylinositol 3,4,5-trisphosphate (PIP3) (Britton et al., 2002, and see below). 
Also, unlike Myc,the growth-promoting Cyclin D/Cdk4 complexes stimulate, and are 
critically dependent on, mitochondrial activity (Frei et al., 2005). These differences 
emphasize the different molecular mechanisms that underlie different types of 
“growth”, and they suggest ways how growth regulators could collaborate even 
though all ultimately control the rate of cellular size increase. 
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3. DNA synthesis 
Myc also strongly influences the nuclear size of polyploid cells in larvae (fat 
bodies, salivary glands, muscles) and in adult egg chambers (somatic follicle cells 
and germline-derived nurse cells). In these cells Myc predominantly controls the rate 
of endoreplication and hence DNA content: whereas overexpression increases DNA 
content in polyploid larval cells by up to 8-fold (Pierce et al., 2004; Berry and 
Baehrecke, 2007; Demontis and Perrimon, 2009), mutation of Myc strongly reduces 
the ploidy of such larval or ovarian cells (Maines et al., 2004; Pierce et al., 2004; 
Pierce et al., 2008; Steiger et al., 2008; Demontis and Perrimon, 2009). Myc does not 
seem to affect the onset of endoreplication, since Myc overexpression does not 
induce premature endocycles (at least in follicle cells; Shcherbata et al., 2004), 
although forced Myc expression can extend the duration of endoreplication (Pierce et 
al., 2004). It is not clear whether Myc is also required for sub-genomic 
polyploidization, i.e. the amplification of specific genes. Thus, chorion genes are 
amplified in wild type follicle cells after they have become polyploid, and this chorion 
gene amplification was reported to occur normally in follicle cell clones that are 
homozygous for a strong Myc-allele dm2 and that are surrounded by phenotypically 
wild type tissue (Maines et al., 2004). In contrast, females that are homozygous for 
the weak Myc-allele dmP1 show reduced chorion gene amplification in their follicle 
cells (Quinn et al., 2004). The reason for these differences is unclear, but the dmP1 
mutant flies clearly suffer from reduced growth rates throughout their body, and it is 
conceivable that this systemically impacts the behavior of follicle cells (e.g. via 
reduced levels of circulating growth factors). 
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Myc activity has less dramatic effects on DNA replication in diploid cells. On one 
hand, Myc overexpression does not trigger polyploidization in diploid cells (and only 
shortens the duration of G1-phase). On the other hand, the loss of Myc slows down 
G1-phase and overall cell division rates, but has a comparatively mild effect on the 
structure of diploid tissues (imaginal discs). This can be seen in Myc Mnt double 
mutant animals, where polyploid tissues remain severely stunted as compared to wild 
type animals (and, as a consequence, such double mutant larvae are considerably 
smaller than the control). In contrast, diploid imaginal discs show normal patterns of 
proliferation and differentiation, and they develop to comparable sizes as wild type 
discs, although they do so more slowly and require several days more for this 
process (Pierce et al., 2008). The same analysis cannot be carried out in Myc single 
mutant animals, since they die before the third larval instar when most of the size 
increase of imaginal discs takes place. However, a genetic trick allows the generation 
of Myc-mutant eye imaginal discs within an animal that is otherwise functionally wild 
type for Myc. Such flies develop to fully viable adults with surprisingly normal-looking 
eyes and heads that are composed of Myc-mutant cells, although these organs are 
clearly smaller than in the control (Steiger et al., 2008; Schwinkendorf and Gallant, 
2009). 
There are two reports, though, showing dramatic effects of forced Myc expression 
on cellular proliferation. Ectopic expression of different transcription factors in 
developing eye-antennal imaginal discs strongly interferes with their development, 
and often results in flies lacking heads altogether (Jiao et al., 2001). This defect can 
be largely overcome by co-expression of Myc, but also by co-expression with Cyclin 
E which specifically controls cell cycle progression, suggesting that in such an 
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artificial situation Myc is able to stimulate the proliferation of diploid imaginal disc 
cells (Jiao et al., 2001). Similarly, certain mutations in the transcription factor Prd 
produce male flies with strongly reduced cellularity in their accessory glands, and 
these deficits can be overcome by ectopic expression of Myc or of Cyclin E (Xue and 
Noll, 2002). The molecular basis of these effects has not been analyzed, and it is 
therefore not known whether Myc directly stimulates the cell cycle machinery or 
whether the effect is more indirect.  
The effects of Myc on DNA replication could be mediated by different 
transcriptional targets. In genome-wide and directed expression analyses several cell 
cycle regulators have been found to respond to changes in Myc levels, e.g. dE2F1, 
RBF, different cyclins, Stg/Cdc25, but it is unclear whether these constitute direct 
Myc targets (Orian et al., 2003; Duman-Scheel et al., 2004; Hulf et al., 2005). A better 
characterized, presumably directly Myc activated gene is the “DNA-replication 
element binding factor” DREF that itself controls the expression of DNA-replication 
related genes such as dE2F, dPCNA, and Cyclin A (Thao et al., 2008). Interestingly, 
the DREF-binding site (DRE) is significantly enriched in the promoters of Myc 
activated genes, raising the possibility that Myc might also cooperate with DREF in 
controlling the expression of S-phase specific targets (Orian et al., 2003). In addition 
to directly controlling DNA replication specific genes, Myc may also influence 
endoreplication rates indirectly, via the same targets that promote growth and overall 
cell size increases in diploid cells. For example, the S-phase regulator Cyclin E 
(which is also essential for endoreplication) has been shown to be controlled 
posttranscriptionally by Myc (at least in imaginal disc cells, but the same may hold 
true for polyploid cells as well; Prober and Edgar, 2000), possibly via Mycʼs effect on 
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ribosome biogenesis and hence protein synthesis (Grewal et al., 2005). Finally, it is 
conceivable that Myc influences DNA replication directly in a transcription-
independent manner, as has been shown for vertebrate Myc (Dominguez-Sola et al., 
2007). However, such an activity has not been demonstrated in Drosophila so far. 
Interestingly, Myc has little (if any) effect on cytoplasmic and overall size in 
polyploid cells. This contrasts with Mycʼs command on the size of diploid cells (see 
above), but also with the ability of another growth-regulator, the insulin signaling 
pathway, to control polyploid cell size (e.g. Demontis and Perrimon, 2009). It is 
conceivable that Mycʼs effect on diploid and on polyploid cells are mediated by 
different sets of targets and constitute separate biological activities of Myc. 
Alternatively, the same downstream effectors of Myc control both diploid cell and 
polyploid cell behaviors, but the two cell types are wired differently to respond either 
with cytoplasmic growth or with endoreplication, respectively.  
4. Apoptosis 
We have seen that overexpression of Myc increases the size of the affected cells 
and organs, but there are limits to this growth-stimulating activity. Excessive Myc 
activity triggers apoptosis that can overcome the gain in tissue mass caused by Myc-
induced growth (with the definition of “excessive” depending on tissue and 
developmental stage). Thus, high level Myc overexpression in eye imaginal discs is 
accompanied by different hallmarks of apoptosis, such as activation of Caspase 3 
and DNA fragmentation as revealed by TUNEL- and acridine orange-staining 
(Montero et al., 2008). The resulting adult eyes are disorganized and rough, they all 
but lack a particular cell type (pigment cells), and their ommatidia are smaller than 
those of flies expressing more moderate levels of Myc – attributes that presumably 
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reflect the death of some cells during ommatidial differentiation, and hence the 
absence of these cells from the mature ommatidia (Steiger et al., 2008). Signs of 
apoptosis are also seen upon Myc overexpression in wing imaginal discs (de La 
Cova et al., 2004; Benassayag et al., 2005; Montero et al., 2008), and expression of 
a mutant form of Myc (with a presumably slightly higher activity than wild type Myc) in 
clones of cells leads to their elimination from the wing disc as a consequence of 
apoptosis (Schwinkendorf and Gallant, 2009). In contrast, Myc overexpression does 
not stimulate or inhibit the autophagic cell death of 3rd instar larval polyploid salivary 
gland cells, nor does a Myc mutation induce autophagy, indicating that some tissue 
types and some modes of cell death are not affected by Myc (Scott et al., 2004; Berry 
and Baehrecke, 2007). 
Importantly, this ability of Myc to induce cell death is not only observed upon 
overexpression. In hypomorphic Myc mutants, where Myc activity is reduced by 
three- to five-fold (but not completely eliminated), some forms of cell death are 
impaired, as would be expected if Myc has a normal role in controlling this process. 
Thus, dmP0 homozygous females do not show the nurse cell death that normally 
occurs in late-stage egg chambers, and this presumably contributes to the sterility of 
these flies (Quinn et al., 2004). Also, dmP0- and dmP1-mutant wing imaginal discs 
show a significantly reduced incidence of apoptosis upon exposure to low doses of X-
rays (up to 10 Gy), although higher doses (50 Gy) evoke similar apoptotic responses 
in wild type and Myc-mutant cells (Montero et al., 2008).  
The molecular pathway by which Myc influences apoptosis is poorly understood. 
Myc overexpression leads to the upregulation of p53 mRNA within one hour of Myc 
induction, raising the possibility that Myc directly activates transcription of p53. 
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However, p53 is not required for the Myc-dependent apoptosis, since Myc equally 
efficiently triggers cell death in p53 null mutant wing imaginal disc cells (Montero et 
al., 2008). In contrast, heterozygosity for chromosomal deletions that simultaneously 
eliminate the four pro-apoptotic genes hid, grim, reaper and sickle (or only three of 
them) strongly reduces Myc-induced apoptosis in wing discs, indicating that these 
proteins are important for this process (de La Cova et al., 2004; Montero et al., 2008). 
These four proteins have previously been shown to bind and inactivate the caspase-
inhibitor dIAP1, resulting in caspase activation and cell death (Steller, 2008). Their 
expression is induced by a variety of pro-apoptotic stimuli, including Myc – and the 
kinetics of induction of reaper and sickle by Myc is comparably rapid as that of p53. 
Thus, Myc might transcriptionally activate these genes, presumably by direct binding 
of Myc:Max heterodimers to E-boxes located in their regulatory regions (Montero et 
al., 2008). However, Myc can also induce cell death through other pathways that do 
not involve E-box containing target genes. This was shown in experiments where 
Mycʼs partner Max was knocked down (Steiger et al., 2008). Myc requires Max for 
binding to E-boxes, and down-regulation of Max abrogates Mycʼs ability to induce E-
box dependent targets and promote overgrowth in the eye – but it leaves intact the 
ability of overexpressed Myc to trigger apoptosis. This suggests that Max-
independent activities such as the activation of RNA polymerase III (see below) 
contribute to Mycʼs pro-apoptotic actions, but the relative contributions of E-box 
dependent and independent targets, and possible differences between different 
tissues and different developmental stages, have not been explored in detail. 
Furthermore, it is not known whether physiological levels of Myc (that are required for 
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the normal apoptotic response to DNA damage, as described above) affect apoptosis 
via the same pathways as overexpressed Myc. 
5. Cell competition 
The notion that Myc affects apoptosis cell-autonomously is familiar to scientists 
studying Myc in vertebrates. In addition, Drosophila Myc also influences cell death 
non-autonomously in neighboring cells, in a process called “cell competition”. 
“Cell competition” was first described 30 years ago in a study of a class of 
mutants called Minutes (Morata and Ripoll, 1975; Simpson and Morata, 1981). There 
are more than 50 different Minute loci in flies, and we now know that most (perhaps 
all) of them code for ribosomal proteins (Lambertsson, 1998). Homozygous Minute 
mutations are cell-lethal, as would be predicted; even heterozygosity for a Minute 
mutation reduces cellular proliferation rate and extends the overall duration of 
development, but ultimately such Minute/+ animals eclose with a normal morphology, 
although their bristles are more slender than those of wild type flies (Lambertsson, 
1998). The process of cell competition is observed when cell clones are generated 
during imaginal disc development such that Minute/+ cells are juxtaposed to +/+ 
cells. While it would be expected that the former grow more slowly than the latter and 
ultimately occupy an accordingly smaller area, the growth defect of Minute/+ cells 
has more dramatic consequences: these cells are killed by the contact with their 
faster growing, healthier neighbors and tend to disappear altogether from the wing 
tissue – even though such Minute/+ cells would have the potential to give rise to a 
complete adult animal as we have seen above. The demise of these Minute/+ cells is 
prevented if the growth rate of the surrounding cells is also decreased (e.g. by 
heterozygosity for a different Minute mutation), or if they are separated from the 
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competing cells by a compartment boundary; i.e. slow-growing cells in the posterior 
compartment of a wing imaginal disc are not affected by adjacent wild type cells in 
the anterior compartment. The final size of the resulting wing is not changed by the 
cell competition taking place during larval wing development, and it has been 
proposed that cell competition serves as a quality control mechanism to replace 
“unfit” cells by their healthier neighbors (de La Cova et al., 2004). 
Cell competition is thought to arise from differences in growth rates between 
adjacent cells, and additional growth regulators have been proposed to affect cell 
competition, e.g. components of the Hippo tumor suppressor pathway (Tyler et al., 
2007) and most notably Myc. A moderate reduction of Myc levels still allows for the 
development of phenotypically normal (albeit small) animals, but the same reduction 
of Myc levels in clones triggers their elimination if they are surrounded by 
phenotypically wild-type cells (Johnston et al., 1999). Conversely, overexpression of 
Myc leads to the death of surrounding wild type cells, even though they are perfectly 
healthy, making these Myc-overexpressing cells “super-competitors” (de La Cova et 
al., 2004; Moreno and Basler, 2004). This process can be triggered by remarkably 
small differences in Myc levels between adjacent cells (presumably two-fold or even 
less), which distinguishes cell competition from the cell-autonomous apoptosis that is 
induced by comparatively high-level Myc overexpression only (Moreno and Basler, 
2004). The study of Myc-dependent cell competition also suggested an additional 
biological function for this process: when apoptosis (and hence cell competition) was 
blocked during the development of wing imaginal discs, the resulting adult wings 
showed considerably higher variability in their sizes, although the average size was 
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the same as in control. Thus, cell competition might also serve to reduce the 
consequences of “developmental noise” (de La Cova et al., 2004). 
The mechanism that senses the subtle differences in Myc activity is currently 
under investigation. Some effector components of the “cell competition pathway” 
have been identified. For example, engulfment of competed Minute/+ cells by their 
wild-type neighbors was shown to be essential not only for the removal of the dead 
cells, but also for allowing these cells to die in the first place (Li and Baker, 2007). In 
the case of Myc-induced competition the pro-apoptotic gene hid also plays an 
important role: competed cells up-regulate hid, and heterozygosity for this gene 
virtually eliminates Myc-dependent cell competition and allows wing disc 
compartments containing competed cells to overgrow (de La Cova et al., 2004). 
However, neither hid nor the engulfment factors explain how differences in cellular 
growth rate are sensed in the first place, and the question remains how the 
competition process is initiated. A candidate upstream factor is the signaling pathway 
activated by the TGFβ-homolog Dpp. In a competing environment Minute/+ cells 
transduce the Dpp signal with reduced efficiency as compared to their surviving 
neighbors, leading to excessive expression of the Dpp-repressed gene Brinker, 
followed by activation of the kinase Jnk and subsequent apoptosis (Moreno et al., 
2002). The involvement of Jnk signaling downstream of Myc-dependent competition 
remains controversial, though (de La Cova et al., 2004), and it has been suggested 
that it is the experimental heat-shock treatment that leads to the activation of Jnk, 
rather than cell competition per se (Tyler et al., 2007). Consistent with a possible 
involvement of Dpp signaling in cell competition, different mutants that prevented the 
competition of Minute/+ cells also re-established Dpp signaling activity (Tyler et al., 
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2007). Conversely, upregulation of the Dpp-pathway in cells suffering from Myc-
dependent competition also rescued their survival (Moreno and Basler, 2004), as did 
the elimination of the Dpp-effector Brinker or its putative transcriptional co-factor 
dNAB (Ziv et al., 2009). The defect in Dpp signaling in the competed cells has been 
suggested to result from impaired endocytosis (Moreno and Basler, 2004), but it is 
still enigmatic which signals could mediate the slight initial differences in Myc activity 
between neighboring cells and subsequently lead to reduced endocytosis and 
presumably additional defects that induce a cell to die. Such signals are likely to be 
diffusible, since cell competition was observed at a distance of up to 8 cell diameters 
between the competed and the competing cell (de La Cova et al., 2004). To find 
these signals a cell-culture based system was developed where Myc-overexpressing 
Drosophila Schneider cells induce apoptosis in naïve Schneider cells (Senoo-
Matsuda and Johnston, 2007). This system mimics several aspects of the cell 
competition observed in the animal (e.g. the ability of Myc-expressing “super 
competitors” to induce apoptosis without direct cell-cell contact), and there is hope 
that this approach, or a genetic screen similar to the one recently published (Tyler et 
al., 2007), will soon unravel the molecular basis of cell competition. Investigations of 
cell competition are fuelled by an interest for its role during normal insect 
development, but in part also by the speculation that an analogous process might 
contribute to human cancers that are characterized by overexpression of one of the 
Myc oncoproteins, although currently no data exist to support this notion (Moreno, 
2008). 
A discussion of cell competition would be incomplete without mentioning the 
phenomenon of “compensatory proliferation” (reviewed by Fan and Bergmann, 
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2008). The term originates from the observation that different types of abuse (e.g. 
strong irradiation, prolonged heat-shock) will kill the majority of imaginal disc cells, 
but nevertheless allow the eclosion of normally shaped adults, since the surviving 
cells increase their proliferation rate and thus replace the dead cells. Before they die, 
such mortally wounded cells synthesize different patterning factors (Wg, Dpp, Hh, 
depending on the tissue type) that might induce the compensatory proliferation of the 
surrounding cells. Whereas the connections between compensatory proliferation and 
cell competition have not been extensively investigated, it is tempting to speculate 
that (while they are dying) the competed cells feed back on the competing cells and 
further stimulate their growth, thus helping to reinforce the “fitness difference” 
between the “winners” and the “losers”. To date there is no evidence for a specific 
involvement of Myc in compensatory proliferation, but it is interesting to note that 
larvae carrying a hypomorphic Myc mutation are more sensitive to ionizing irradiation 
than control animals (Jaklevic et al., 2006), even though their wing disc cells show a 
reduced rate of apoptosis (Montero et al., 2008). One possible explanation for this 
observation is that these animals might suffer from a defect in compensatory 
proliferation. However, the increased sensitivity to irradiation is not restricted to Myc 
mutations, as disruption of other growth regulators (e.g. Cdk4, the Insulin pathway) 
results in a similar defect (Jaklevic et al., 2006). Given the current interest in cell 
competition, compensatory proliferation and Myc, it is likely that any missing 
molecular links between these three will soon be uncovered. 
6. Asymmetric stem cell division 
Another similarity between vertebrates and Drosophila resides in the involvement 
of Myc in stem cell biology. One tissue where this function of Myc has been studied is 
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the female germline. Oogenesis in Drosophila takes place in about 18 ovarioles per 
ovary (reviewed in Fuller and Spradling, 2007; Bastock and St Johnston, 2008). At 
one end of each of these ovarioles resides a stem cell niche harboring 2 to 3 germ-
line stem cells (GSCs). These stem cells undergo asymmetric divisions, producing 
another GSC and a differentiating cystoblast, which will divide four more times to 
form an egg chamber that then develops into an oocyte. Myc protein is highly 
expressed in the GSCs, but drops to low levels in their daughter cystoblasts (by a 
poorly defined mechanism involving the protein Mei-P26), before it rises again during 
later stages of oogenesis (Neumuller et al., 2008; Rhiner et al., 2009). When Myc 
levels are kept artificially high by means of a constitutively expressed transgene, the 
differentiating cystoblasts maintain a stem cell-like morphology and retain the ability 
to efficiently transduce the Dpp signal (emanating from the stem cell niche), 
suggesting that the drop in Myc levels contributes to the differentiation of these cells, 
although it is not clear how (Rhiner et al., 2009). Interestingly, GSCs can also 
compete with each other for niche occupancy, similar to the cell competition in 
imaginal discs that was discussed above. The involvement of Myc in this type of 
competition is controversial, though – two recent publications came to opposite 
conclusions in this regard. The group of E.Moreno found hypomorphic Myc-mutant 
GSCs to be driven from the niche by adjacent wild type GSCs, whereas GSCs with 
higher than normal Myc levels behaved as “super competitors” and chased away the 
neighboring wild type GSCs (Rhiner et al., 2009). In contrast, T.Xie and coworkers 
observed no competitive disadvantage in Myc-null mutant GSCs as compared to their 
wild type neighbors, nor any competitive advantage of Myc-overexpressing GSCs 
(Jin et al., 2008). It is conceivable that differences in overexpression regimes and in 
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the examined Myc mutant alleles are responsible for this discrepancy. For now, the 
jury is still out whether Myc is also involved in GSC competition. 
However, Myc is likely to play a role in other stem cell divisions as well. Similar to 
GSCs, larval neuroblasts contain high levels of Myc protein (Betschinger et al., 
2006). These cells divide in a stem cell-like manner, producing another neuroblast 
and a ganglion mother cell (GMC), which then gives rise to differentiated neurons. As 
in the germline, Myc levels are considerably lower in the differentiating GMCs than in 
their stem cell mothers. Both the asymmetric neuroblast division and the 
downregulation of Myc in GMCs require the protein Brat (brain tumor). During the 
neuroblast division Brat localizes to the GMC where it downregulates Myc post-
transcriptionally. In Brat mutants neuroblasts divide to produce two additional 
neuroblasts, and the levels of Myc protein remain high in both of these daughter 
cells. Interestingly, Brat and Mei-P26 have a similar domain architecture (both 
containing a “B-Box” and an “NHL domain”) and they share at least one interaction 
partner (the RNase Argonaute1, which is a key component of the miRNA-producing 
RISC complex), suggesting that both proteins might control Myc levels by a similar 
mechanism. 
These studies did not address a functional requirement for Myc in neuroblast 
divisions, but two other reports revealed an effect of Myc on neurogenesis. First, the 
Myc gene was identified as a quantitative trait locus for adult bristle number – a 
hypomorphic mutation in Myc reduced the number of abdominal and sternopleural 
bristles (Norga et al., 2003). Second, overexpression of Myc in the embryonic CNS 
increased the number of neuroblasts, consistent with the idea that Myc might 
promote neuroblast self-renewal at the expense of producing differentiating daughter 
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cells (Orian et al., 2007). Myc is normally expressed in these embryonic neuroblasts, 
where it was proposed to act by binding to the transcriptional co-repressor Groucho 
and thereby antagonizing Grouchoʼs repressive activity. Some of the common target 
genes of Myc and Groucho have an established role in the development of the CNS, 
but interestingly, they lack the typical Myc:Max binding sites (E-boxes) and they have 
also not been identified as Max or Mnt targets (Orian et al., 2003), suggesting that 
Mycʼs action on Groucho and on these targets might be independent of Max (Orian et 
al., 2007). This is most probably not the only mechanism by which Myc influences 
stem cell fate. Brat-mutant, Myc-overexpressing larval neuroblasts are characterized 
by larger nucleoli (Betschinger et al., 2006), as are Myc-overexpressing imaginal disc 
and salivary gland cells (Grewal et al., 2005), raising the possibility that Mycʼs 
general growth-stimulating activity might contribute to “stemness”. 
7. Other functions 
The enumeration of Drosophila Mycʼs biological activities is necessarily 
incomplete. Several abstracts or short descriptions have been published that suggest 
additional functions for Myc that are not obviously connected to any of the processes 
described above. For example, during oogenesis Myc presumably controls the 
migration of follicle cells, in particular of a subpopulation called “border cells” (King 
and Vanoucek, 1960; King, 1970). It is to be expected that we will learn more about 
additional Myc activities in the future. 
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C. Molecular mechanism of Myc action – the partners 
The genetic tractability of Drosophila holds great promise for the functional 
analysis of proposed transcriptional co-factors of Myc and the identification of novel 
such co-factors, and hence for the characterization of the mechanism by which Myc 
controls the expression of its target genes. To date, studies have been published that 
address the function of the DNA helicases Tip48 and Tip49, of Max, the co-repressor 
Groucho, several Trithorax- and Polycomb-group proteins, as well as the Myc-
antagonist Mnt (Figure 3). 
1. Max 
The first identified Myc partner, and arguably the best characterized, is the 
BHLHZ protein Max. Different studies in vertebrate tissue culture cells have 
convincingly demonstrated that Myc requires the association with Max in order to 
bind to E-boxes and control the activation of the corresponding targets (Amati et al., 
1992; Kretzner et al., 1992), but also for the repression of genes lacking E-boxes 
(Facchini et al., 1997; Mao et al., 2003). A mutated form of vertebrate c-Myc that 
cannot associate with Max is incapable of transforming cultured rat embryo 
fibroblasts, or of stimulating cell cycle progression or inducing apoptosis in 
established rat fibroblasts (Amati et al., 1993a; Amati et al., 1993b). Based on these 
and similar observations it was speculated that all functions of Myc might depend on 
Max, because Myc might require the dimerization with Max for its correct folding 
(Adhikary and Eilers, 2005). It therefore came as surprise that Drosophila Myc retains 
substantial activity even in the absence of Max (Steiger et al., 2008). This is most 
strikingly demonstrated by the phenotypic differences between Myc- and Max-mutant 
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animals: flies lacking Myc altogether fail to grow and mostly die as small larvae, 
whereas up to a third of Max-null mutant flies initiate metamorphosis and many of 
them even reach the pharate adult stage (i.e. they develop all adult body structures 
but they do not manage to leave the pupal case and die at this stage). 
Part of this difference can be explained by the Myc antagonist Mnt, whose activity 
is also lost in Max mutants but not in Myc mutants: Myc Mnt doubly mutant animals 
survive for longer and grow larger than Myc singly mutant animals, presumably 
because typical Myc-activated genes are expressed at higher levels in Myc Mnt 
larvae than in Myc mutants (although still substantially lower than in control animals). 
This indicates that Myc functions in part to derepress Mnt-repressed genes (Pierce et 
al., 2008), as has been shown in vertebrate studies (Nilsson et al., 2004; Hurlin et al., 
2003). However, Myc retains substantial activity in the absence of Max, and Myc Mnt 
doubly mutant animals clearly do not grow as well and do not develop as far as Max 
mutants. Thus, endoreplication is only partially impaired by the loss of Max but 
strongly by the loss of Myc, overexpressed Myc is capable of inducing cell-
autonomous apoptosis in the absence of Max, and differences in Myc levels still 
trigger cell competition in Max-mutant animals. These observations point to the 
existence of substantial Max-independent activities of Myc. At least some of these 
may reside in Mycʼs interaction with RNA polymerase III (Steiger et al., 2008). It has 
previously been found that vertebrate Myc can activate RNA polymerase III, and that 
Myc does so by physically interacting with the polymerase III cofactor Brf (Gomez-
Roman et al., 2003). This activity of Myc was shown to be conserved in flies, i.e. 
Drosophila Myc activates RNA polymerase III targets and is required for their full 
expression, and Drosophila Myc physically and genetically interacts with Brf (Steiger 
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et al., 2008). Importantly, both Mycʼs effect on Pol III targets and its interaction with 
Brf are also observed in the absence of Max. Thus, this effect on polymerase III may 
explain some of the observed differences between Myc (or Myc Mnt) and Max 
mutants, but there are likely to be additional functions of Myc that do not rely on the 
association with Max. 
2. Groucho 
One of these may be mediated by the transcriptional co-repressor Groucho (Orian 
et al., 2007). Groucho was found to associate with several genes that are also bound 
by Myc but lack known Myc:Max-binding sites (E-boxes). It is possible that Myc and 
Groucho are recruited to these genes together in the absence of Max, since Myc and 
Groucho also physically associate in vivo and in vitro. Several of these common 
targets play a role in neurogenesis and mitosis, and it was proposed that Groucho 
and Myc antagonistically control these genes and thereby affect the neuronal 
development: Groucho mediates the activity of the Notch-signaling pathway in 
repressing these genes, whereas Myc acts downstream of the EGF-receptor in 
activating them and promoting neuronal specification (Orian et al., 2007). While this 
observation suggests an interesting new role for Myc, the mechanistic details of the 
Myc:Groucho interaction still need to be worked out. In particular, the additional 
components of the Myc:Groucho complex need to be identified, that determine how 
the complex gets recruited to its target genes and how it controls their expression. 
3. Tip48 & Tip49 
In contrast to Groucho, the DNA helicases Tip48 and Tip49 have already been 
identified in studies in vertebrate tissue culture cells as putative co-activators for Myc 
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(Wood et al., 2000). The analysis of their Drosophila homologs (called Pontin and 
Reptin, respectively) confirmed their physical interaction with Myc and the existence 
of a ternary Myc:Pontin:Reptin complex, and further showed that Pontin (and to a 
lesser extent Reptin) is essential for Myc-dependent growth in vivo (Bellosta et al., 
2005). Unexpectedly, Pontin could not be shown to play a role in Myc-dependent 
gene activation, but instead in Myc-dependent gene repression. An analogous 
repressive function was investigated in greater detail for the Xenopus homologs of 
Pontin (and Reptin). Both proteins were demonstrated to be essential for the ability of 
Xenopus Myc to repress the transcriptional activator Miz-1 and prevent it from 
activating the cell cycle inhibitor p21 (Etard et al., 2005). These observations further 
confirm the similarity between insect and vertebrate Myc. The mechanistic basis for 
the action of Pontin and Reptin remains open, though, as both proteins can act in 
several different transcription-associated complexes and it is not clear which of them 
is responsible for the observed repressive effects (Gallant, 2007). 
4. Polycomb- and Trithorax-group proteins 
The identification of Polycomb- and Trithorax-group genes in genetic screens 
emphasizes the potential of Drosophila for the discovery of novel Myc co-factors. The 
Trithorax-group genes ash2 (“Absent, small, or homeotic discs 2”; the homolog of 
vertebrate ASH2L), brahma (the homolog of human hBrm and Brg1) and lid (“Little 
imaginal discs”; the homolog of vertebrate Rbp-2/JARID1A and PLU-1/JARID1B) 
were found to be required for overexpressed Myc to promote overgrowth (Secombe 
et al., 2007). The three proteins physically interact with Myc in two separate 
complexes, one containing Ash2 and Lid, the other one containing Brahma. Lid was 
further shown to be required for the full activation of at least one direct Myc-activated 
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gene. Such a role in gene activation is consistent with Lidʼs classification as a 
Trithorax-group protein (as Trithorax proteins generally play a positive role in 
transcription), but appears at odds with Lidʼs molecular activity as a histone H3 lysine 
4 trimethyl (H3K4me3) demethylase, as trimethylation on H3K4 is generally 
associated with active transcription. However, this demethylase activity does not 
seem to be required for Lidʼs ability to cooperate with Myc in vivo, since a mutant 
form of Lid lacking the demethylase domain also enhanced a Myc-overexpression 
phenotype, and since binding to Myc inhibits this demethylase activity. This does not 
explain how Lid helps Myc in the activation of its targets, but an answer might be 
found in the recent observation that Lid can associate with, and inhibit, the histone 
deacetylase Rpd3 in a potentially demethylase-independent manner, and thereby 
promote the transcription of certain target genes (Lee et al., 2009). The roles of Ash2 
and Brahma can more easily be rationalized, as Ash2 is known from other studies to 
be associated with H3K4 trimethyltransferases and Brahma is a component of the 
SWI/SNF chromatin remodeling complex, and hence both have a documented 
function in transcriptional activation.  
In an independent screen, Pc (“Polycomb”; the homolog of human CBX2/4/8), Psc 
(“Posterior sex combs”; the homolog of vertebrate Bmi1), Pho (“Pleiohomeotic”; the 
homolog of vertebrate YY1), and Ash1 (“Absent, small, or homeotic discs 1”; the 
homolog of vertebrate ASH1L) were found to affect the expression of some Myc 
targets during embryogenesis (Goodliffe et al., 2005; Goodliffe et al., 2007). Some of 
these targets were activated by Myc and by these other proteins, others (including 
the Myc locus itself) were repressed by both, and yet others were repressed by Pc 
and Pho, but activated by Myc. However, none of these proteins has been shown to 
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physically associate with Myc so far, and it is possible that their influence on Myc 
target gene expression is indirect. For example, it has been suggested that Ash1 
functions as an H3K4 mono- and dimethyltransferase, thereby creating a substrate 
for the subsequent H3K4 trimethylation by an Ash2-containing complex (Byrd and 
Shearn, 2003). It is conceivable that Myc (in conjunction with an Ash2-complex) is 
involved in such a H3K4 trimethylation, and thereby (indirectly) depends on the prior 
activity of Ash1. Alternatively, Ash2 might help recruit Myc to genes that are already 
trimethylated on H3K4, as this post-translational modification has been shown to 
predate Myc recruitment to its targets in vertebrates (Guccione et al., 2006). It is 
currently unclear how Pc and Pho (which are both found in the same complex, PRC1; 
Schuettengruber et al., 2007) affect Myc targets. 
Finally, a close functional connection between Myc and Trithorax-/Polycomb-
group proteins was also suggested by the recent comparison of Myc targets with 
those of Trx (“trithorax”, homolog of vertebrate MLL proteins). Many of these genes 
were found to be arranged in clusters, and most of these target clusters were shared 
between Myc and Trx (Blanco et al., 2008). Whereas the molecular mechanisms of 
the interactions between Myc and these Polycomb-/Trithorax-proteins still need to be 
worked out, there is a good chance that (some of) this mechanism is conserved in 
vertebrates, since the vertebrate homologs of Lid (Secombe et al., 2007), Ash2 
(Luscher-Firzlaff et al., 2008), Brahma (Cheng et al., 1999), Psc/Bmi1 (e.g. Jacobs et 
al., 1999) and Pho/YY1 (Shrivastava et al., 1993; Austen et al., 1998) all were shown 
to physically and/or functionally interact with vertebrate Myc. 
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5. The Myc protein 
The sections above have addressed different trans-acting factors that collaborate 
with Myc in the control of gene expression. In addition, the fruit fly has also been 
used to analyze the requirement of parts of the Myc protein itself for the 
transcriptional regulation (Schwinkendorf and Gallant, 2009). Previous work in 
vertebrate tissue culture systems had identified Myc box 2 (MB2) as important for 
transactivation and –repression, and as generally essential for all biological activities 
of Myc proteins. This domain is highly conserved in Drosophila Myc, and it therefore 
came as surprise that it is partially dispensable for Myc function in vivo. A mutant 
Myc protein lacking MB2 can rescue the lethality of a substantial fraction of flies 
lacking all endogenous Myc, indicating that MB2 only modulates Myc activity, but is 
not essential for it. The co-factors contacting MB2 in Drosophila (that are therefore 
partially dispensable for Myc function in vivo) still need to be identified 
(Schwinkendorf and Gallant, 2009). 
It is to be expected that future experiments in Drosophila will result in the 
identification of additional transcriptional co-factors for Myc. It will be important to 
explore the possible connections between the different Myc partners mentioned 
above (as well as between these proteins and the sequence motifs within Myc itself). 
It is likely that Myc recruits different enzymatic activities to control the expression of 
its target genes, and hence that some of these factors associate separately with Myc, 
but it is also conceivable that some of these proteins that have been analyzed 
separately so far are located in the same multi-protein complexes.  
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D. Control of Myc activity 
A large variety of inputs controls Myc activity in vertebrates (reviewed in Spencer 
and Groudine, 1991; Liu and Levens, 2006). In Drosophila, fewer such signals have 
been reported to date, simply because this subject has not yet been investigated to 
the same depth, but the short half-life of Drosophila Myc raises the possibility of an 
equally tight regulation: whereas the stability of Drosophila Myc mRNA has not been 
determined yet, Drosophila Myc protein decays with a half-life of 30-60ʼ, comparable 
to that of its vertebrate counterparts (Galletti et al., 2009; Schwinkendorf & Gallant, 
unpublished data). The pathways currently known to affect this protein stability or 
Mycʼs expression are summarized below (Figure 4). 
1. Control of Myc expression 
During early embryogenesis, maternally deposited Myc mRNA is ubiquitously 
distributed in all cells (Gallant et al., 1996). Fertilization destabilizes this maternal 
message (as is the case for 21% of all maternal transcripts), such that its levels are 
significantly reduced in 4-6 hour old embryos (Tadros et al., 2007). Zygotic Myc 
transcripts then accumulate in the presumptive mesoderm, presumably under the 
control of the mesoderm specifying transcription factor Twist, which has been shown 
to bind to the Myc gene (Sandmann et al., 2007). Later, Myc is induced (by some as 
yet unknown mechanism) in the cells of the gut and salivary placodes (Gallant et al., 
1996). 
During larval development, Myc transcripts can be broadly detected in most 
diploid and polyploid cells. However, in the second half of the 3rd larval instar, a stripe 
of cells along the future wing margin, called the “zone of non-proliferating cells” 
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(ZNC), exits from the cell cycle and down-regulates Myc expression. This Myc 
repression is mediated by the Wingless signaling pathway, as the expression of 
dominant-negative Pangolin/TCF (the transcription factor at the end of the Wingless 
cascade) prevents this down-regulation and the cell cycle exit of the ZNC cells (as 
does forced expression of Myc; Johnston et al., 1999; Duman-Scheel et al., 2004). It 
is not clear, though, whether TCF directly represses Myc expression. According to 
one report, Wingless signaling up-regulates a protein called Half-pint (Hfp), which in 
turn represses Myc (Quinn et al., 2004; interestingly, Hfp is also repressed by the 
molting hormone ecdysone via the zinc-finger transcripton factor Crooked Legs/Crol, 
indicating that ecdysone can also positively regulate Myc expression: Mitchell et al., 
2008). Mutation of Hfp leads to increased Myc mRNA levels in imaginal disc clones 
(including clones that extend into the ZNC) and in egg chambers. Consistent with 
this, heterozygosity for Hfp suppresses the female sterility associated with 
hypomorphic Myc alleles. Hfp is the Drosophila homolog of vertebrate FIR (“FBP 
interacting protein”), which was shown to repress vertebrate c-Myc through the “far 
upstream sequence element” (FUSE) (Liu et al., 2000), raising the possibility that Hfp 
directly binds to and represses the Myc gene – although no FUSE has been identified 
in Drosophila Myc so far (Quinn et al., 2004). 
A separate report showed that Wingless signaling (and TCF) acts by repressing 
the Notch pathway, which in turn represses Myc (Herranz et al., 2008). An opposite 
effect of Notch on Myc expression was observed in larval neuroblasts, where a 
mutation of Aurora A kinase leads to up-regulation of Notch and subsequent 
induction of Myc (Wang et al., 2006). The molecular basis for either of these Notch 
effects is currently unknown, but it is interesting to note that a genetic interaction 
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between the Notch pathway and Myc has been reported (Muller et al., 2005; Orian et 
al., 2007). It remains possible that Notch also affects Hfp expression, or that Hfp, 
Notch (and possibly TCF) provide separate and parallel inputs into Myc expression. 
As might be expected, Myc expression is also affected by the major growth-
regulating axis in Drosophila: the insulin receptor (Inr) / target-of-rapamycin (TOR) 
pathway. This pathway monitors the flyʼs nutrient status: when food is copious, Inr 
signaling stimulates protein synthesis and induces the phosphorylation and 
inactivation of the transcription factor Foxo; at the same time, TOR activity increases 
translation rates and the transcription of growth-activating genes. On the other hand, 
upon starvation Inr and TOR are reduced in their activity, Foxo is dephosphorylated, 
enters the nucleus and binds its target genes – including Myc (Teleman et al., 2008). 
The consequences of Foxo binding for Myc expression are ambiguous, though, as 
shown by either site-directed mutation of the Foxo-binding site in the Myc promoter or 
by mutational inactivation of Foxo itself. Both treatments increase Myc expression in 
the fat body of fed larvae (i.e. in a situation where Foxo is normally kept inactive by 
Inr signaling), but they reduce Myc expression in starved larvae (where Foxo is 
normally active). The situation is different again in larval muscles, where the deletion 
of the Foxo binding site has no effect on Myc mRNA levels, but a Foxo mutation 
increases Myc levels specifically in starved larvae. These observations show that the 
action of Foxo on Myc levels depends on tissue type and nutritional status of the 
animal, although the basis for these differences is currently not known. Taking into 
consideration that TOR signaling also controls Myc protein levels (see below), and 
that Foxo was also proposed to affect Myc activity independently of Myc levels 
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(Demontis and Perrimon, 2009), it is difficult to predict how Inr, TOR and Myc actually 
cooperate in the control of growth at the organismal level.  
Growth is also controlled by the evolutionarily conserved Hippo / Yorkie signaling 
pathway. One of the upstream regulators of this pathway is the transmembrane 
protein Fat (reviewed by Reddy and Irvine, 2008). Mutations in Fat induce tissue 
overgrowth. This overgrowth is accompanied by increased expression of Myc and 
hypomorphic mutations in Myc strongly reduce the growth-promoting effect of Fat 
(Garoia et al., 2005). These observations suggest that the Hippo / Yorkie pathway 
also controls Myc transcription. 
Finally, Drosophila Myc has been shown to autorepress its own expression 
(Goodliffe et al., 2005). Like in vertebrates, this autorepression requires dimerization 
of Myc with Max (Facchini et al., 1997; Steiger et al., 2008), and it involves the 
Trithorax- and Polycomb-proteins discussed above (Pc, Pho, Psc, Ash2; Goodliffe et 
al., 2005; Goodliffe et al., 2007), but the relevant cis-acting sequences in the Myc 
gene have not been analyzed yet.  
Thus, Myc transcript levels might be as tightly regulated in flies as they are in 
vertebrates. Surprisingly, though, such a tight control does not seem to be essential 
for Drosophila development. A transgene directing ubiquitous expression of a Myc 
cDNA (under the control of the α-Tubulin promoter) is able to fully rescue the 
development of Myc null-mutant flies, although these rescued animals suffer from a 
slight growth deficit (Schwinkendorf and Gallant, 2009). This suggests either that the 
physiological pattern of Myc activity is not required for development, or that (partially 
redundant) mechanisms control Myc activity at the post-transcriptional stage. Indeed, 
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several such pathways have been identified in recent years, and they are 
summarized below. 
2. Control of Myc protein levels 
The stability of vertebrate Myc is regulated by the ubiquitin proteasome pathway. 
Briefly, the Ras/Raf/ERK kinase cascade leads to the phosphorylation of serine 62 
(S62, located within Myc box 1 / MB1). This phosphorylation has a stabilizing effect 
on Myc, but it is also a prerequisite for the phosphorylation of threonine 58 (T58, also 
within MB1) by GSK3β. The doubly phosphorylated (T58 S62) protein is then 
dephosphorylated on S62 by the consecutive actions of the prolyl isomerase Pin1 
and protein phosphatase 2A (PP2A), which in turn leads to Mycʼs ubiquitination by 
the E3 ubiquitin ligase Fbw7 and subsequent degradation. These different reactions 
are facilitated by the scaffolding protein Axin, which binds several of the involved 
proteins, including Myc (reviewed by Sears, 2004; Schulein and Eilers, 2009). 
This pathway is (at least partially) conserved in flies. Thus, Myc levels are post-
transcriptionally increased in imaginal disc cells expressing activated Ras (RasV12) 
(Prober and Edgar, 2002; note, though, that a different publication observed no such 
up-regulation of Myc upon overactivation of the EGF-receptor that acts upstream of 
Ras: Parker, 2006). On the other hand, the kinase GSK3β (called Shaggy / Sgg in 
Drosophila) triggers ubiquitination of Myc in cultured cells and, as a consequence, 
decreases Myc stability in tissue culture and in imaginal discs in vivo (Galletti et al., 
2009). An involvement of Axin has not been demonstrated yet. Interestingly, though, 
another kinase known to associate with Axin, Casein Kinase 1α (CK1α) (Huang and 
He, 2008), has similar effects on Myc as GSK3β in cultured cells (and to some extent 
in vivo as well). MB1 and hence the phosphorylation site for GSK3β in vertebrate c-
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Myc is not well conserved in Drosophila Myc, but two other putative targets for 
phosphorylation by GSK3β and CK1α have been identified, and their mutation 
strongly increases Myc stability. One of these sites is located within an acidic stretch 
that is highly conserved across Myc proteins from different species and that has been 
dubbed Myc box 3 (MB3), the function of which has remained mysterious in the past 
(Galletti et al., 2009). Another conserved player in the degradation pathway is the F-
box containing E3 ubiquitin ligase Ago (“Archipelago”; homolog of vertebrate Fbw7; 
Moberg et al., 2004). Ago physically interacts with Myc and targets it for degradation. 
Loss of Ago in cell clones increases Myc protein levels and the size of these clones; 
heterozygosity for Ago in entire animals reduces the growth deficit of hypomorphic 
Myc mutant flies and increases their fertility. It is not known which sequence in the 
Myc protein contacts Ago, since the Fbw7 interaction site in vertebrate c-Myc (MB1) 
is only poorly conserved. However, Drosophila Myc contains several suboptimal Ago 
binding sites, and one of them coincides with MB3, suggesting that the 
phosphorylation of this domain by CK1α and GSK3β triggers recognition by Ago and 
subsequent degradation of Myc (Moberg et al., 2004; Galletti et al., 2009).  
Having identified these proteins that regulate Myc stability, it will be of obvious 
interest to characterize the upstream inputs that feed into this degradation pathway. 
GSK3β is known to be controlled by the Inr signaling pathway, but so far no effects of 
this pathway on Myc stability have been reported. On the other hand, the TOR kinase 
has been shown to feed back on components of the Inr pathway, including GSK3β 
(e.g. Sarbassov et al., 2005; Zhang et al., 2006). Since rapamycin-mediated inhibition 
of TOR has been shown to reduce Myc protein levels post-transcriptionally (Teleman 
et al., 2008), it is conceivable that this effect is mediated by the pathway outlined 
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above. This report also identifies Myc as a downstream mediator of TORʼs growth-
promoting effects. Consistent with this observation, reduced TOR activity (caused by 
expression of either the negative upstream regulators TSC1 and TSC2 or a 
dominant-negatively acting TOR itself) can be overcome by ectopic expression of 
Myc (Tapon et al., 2001; Hennig and Neufeld, 2002).  
TOR is certainly not the only regulator that affects the levels of Myc protein. One 
additional family of proteins that control Myc levels has been identified in 
asymmetrically dividing stem cells. As mentioned above, in neuroblasts mutation of 
Brat post-transcriptionally elevates Myc protein levels (Betschinger et al., 2006), and 
in female germline stem cells, the loss of Mei-P26 has a similar effect (Neumuller et 
al., 2008; Rhiner et al., 2009). Brat and Mei-P26, as well as a third Drosophila protein 
called Dappled, are related in domain structure, suggesting that they might affect Myc 
levels through a common mechanism. This mechanism appears to be evolutionarily 
conserved, as a vertebrate homolog of these proteins, TRIM-32, was recently shown 
to mediate ubiquitination and subsequent degradation of c-Myc (Schwamborn et al., 
2009).  
These different observations suggest the existence of several mechanisms that 
control Myc levels. It will be interesting to determine the molecular details of these 
pathways, as well as possible connections to the “core degradation machinery” 
described above. 
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E. Outlook 
Myc proteins have fascinated biomedical researchers for 30 years. This interest is 
largely explained by the enormous impact of Myc mutations on human health. In 
addition, Mycʼs central role in coordinating growth during normal development has 
become increasingly obvious in recent years. The discovery of the Myc/Max/Mxd 
network in Drosophila has opened a new experimental window for addressing these 
physiological functions of Myc. Research in the fruit fly has already contributed 
significantly to our understanding of pathological and physiological Myc function in 
vertebrates, for example by pinpointing the control of cellular growth as an essential, 
evolutionarily conserved role of Myc. Additional findings made in Drosophila are likely 
to be valid for the vertebrate system as well, such as the realization of Max-
independent functions of Myc and the identification of alternative mechanisms of 
transcriptional control by Myc. Similarly, I expect the results of the genetic screens in 
Drosophila to play an important role in shaping our molecular understanding of the 
Max network, in flies as well as in vertebrates.  
Beyond the molecular dissection of Mycʼs transcriptional function, Drosophila will 
be increasingly used to uncover systemic interactions with the different pathways 
controlling organismal development. These include the Insulin, TOR and 
Hippo/Salvador/Warts signaling pathways, which have been defined as the major 
determinants of body size. In addition, the effect of extrinsic factors, such as food 
availability, on Max network activity need to be addressed. Drosophila offers an ideal 
experimental system for investigating such issues, and we can expect significant 
advances in the near future. Stay tuned! 
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VII. Figure legends 
Figure 1. Domain structure of the Drosophila Myc, Max and Mnt proteins. 
Domain names are explained in the main text. MB1 is only tentatively indicated as it 
shows low sequence similarity to the corresponding domain in vertebrate Myc 
proteins. The exact extents of the regions involved in transactivation, transrepression 
and protein stability are not known. The BHLHZ domains mediate dimerization with 
Max and DNA-binding. The numbers to the right show the the protein lengths (in 
amino acids). 
Figure 2. Activities of Myc. Myc controls the activity of RNA Polymerases II and 
III, and (indirectly) of RNA Polymerase I. Their targets (together with possible 
transcription-independent activities of Myc) affect the indicated cellular processes. 
Figure 3. Myc-interacting proteins. The depicted proteins have been shown to 
(directly or indirectly) bind to Myc. The colors indicate whether the corresponding 
proteins are thought to contact Myc:Max complexes (greenish shades) or interact 
with Myc independently of Max (reddish shades); no pertinent information exists for 
the proteins shown in grey. Some putative functions of the interacting proteins are 
also shown. Full protein names are (in parentheses: vertebrate homologs): Ash2 / 
“absent, small, or homeotic discs 2” (ASH2L), Brf (BRF1), Brm / Brahma (Brg1, 
hBrm), Gro / groucho (TLE), Lid / “little imaginal discs” (Rbp-2/JARID1A, PLU-
1/JARID1B), Pont / Pontin (TIP49/RUVBL1), Rept / Reptin (TIP48/RUVBL2). 
Figure 4. Upstream regulators of Myc. Proteins in the top half affect Myc mRNA 
abundance (presumably transcriptionally), whereas the proteins in the lower half act 
post-transcriptionally on Myc protein levels. Proteins that are thought to act in the 
same pathway (e.g. Wg, Hfp and Notch) or use the same molecular mechanism (e.g. 
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Brat and Mei-P26) are grouped together. The directionality of the effect (increase 
versus decrease of Myc levels) is reflected in the shape of the arrows and the color of 
the proteins (red or green, respectively). The effects of Notch and Foxo are 
ambiguous. Full protein names are (in parentheses: human homologs): Ago / 
archipelago (FBXW7), Ash1 / “absent, small, or homeotic discs 1” (ASH1L), Brat / 
“brain tumor” (similar to TRIM32), CK1α / “Casein kinase 1α”, Foxo / “forkhead box, 
sub-group O” (FOXO3), Hfp / pUf68 = “poly U binding factor 68kD” (FIR / PUF60), 
Mei-P26 (similar to TRIM32), Pc / Polycomb (CBX2/4/8), Pho / pleiohomeotic (YY1), 
Psc / “Posterior sex combs” (Bmi1, Mel-18), Sgg / shaggy (GSK3β), TOR / “Target of 
rapamycin” (mTOR), Twist (TWIST), Wg / Wingless (Wnt). 




